Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

<p>The Climate is Changing for Metered-Dose Inhalers and Action is Needed</p>
J.N. Pritchard
Drug Design Development and Therapy (2020) Vol. Volume 14, pp. 3043-3055
Open Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

Inhaled Medicines: Past, Present, and Future
Sandra D. Anderson, Paul J. Atkins, Per Bäckman, et al.
Pharmacological Reviews (2022) Vol. 74, Iss. 1, pp. 48-118
Open Access | Times Cited: 69
A comprehensive overview of dry powder inhalers for pulmonary drug delivery: Challenges, advances, optimization techniques, and applications
Hend I. Shahin, Lipika Chablani
Journal of Drug Delivery Science and Technology (2023) Vol. 84, pp. 104553-104553
Closed Access | Times Cited: 25
Developing a guide for sustainable healthcare practice: A case study from the Swedish Society of Medicine
Andreas Vilhelmsson, Ida Persson Cofina, Maria Wolodarski, et al.
The Journal of Climate Change and Health (2025), pp. 100413-100413
Open Access
Clinical effectiveness and implementation outcomes of pMDI-to-DPI switch in children between 5 and 12 years of age: a scoping review protocol
Amanda Zain, Alston Zhao Yi Ng, I Yeo, et al.
BMJ Open (2025) Vol. 15, Iss. 1, pp. e088846-e088846
Open Access
The environmental impact of inhalers for asthma: A green challenge and a golden opportunity
Alex Wilkinson, Ashley Woodcock
British Journal of Clinical Pharmacology (2021) Vol. 88, Iss. 7, pp. 3016-3022
Open Access | Times Cited: 51
“As-Needed” Inhaled Corticosteroids for Patients With Asthma
Juan Carlos Cardet, Alberto Papi, Helen K. Reddel
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 3, pp. 726-734
Open Access | Times Cited: 15
The environmental impact of inhaled therapy: making informed treatment choices
Ashley Woodcock, Kai Michael Beeh, Hironori Sagara, et al.
European Respiratory Journal (2021) Vol. 60, Iss. 1, pp. 2102106-2102106
Open Access | Times Cited: 38
Global access and patient safety in the transition to environmentally friendly respiratory inhalers: the Global Initiative for Asthma perspective
Mark L Levy, Eric D. Bateman, Keith Allan, et al.
The Lancet (2023) Vol. 402, Iss. 10406, pp. 1012-1016
Open Access | Times Cited: 13
Understanding the feasibility and environmental effectiveness of a pilot postal inhaler recovery and recycling scheme
Anna C Murphy, David Howlett, Aaron Gowson, et al.
npj Primary Care Respiratory Medicine (2023) Vol. 33, Iss. 1
Open Access | Times Cited: 12
Impact of choice of inhalers for asthma care on global carbon footprint and societal costs: a long-term economic evaluation
Kalé Kponee-Shovein, Jessica Marvel, Ryotaro Ishikawa, et al.
Journal of Medical Economics (2022) Vol. 25, Iss. 1, pp. 940-953
Open Access | Times Cited: 15
Understanding the performance of pressurized metered dose inhalers formulated with low Global warming potential propellants
Hui Wang, J. Sánchez Leal, Mani Ordoubadi, et al.
Aerosol Science and Technology (2024) Vol. 58, Iss. 2, pp. 115-133
Closed Access | Times Cited: 2
Klimabewusste Verordnung von Inhalativa – Umsetzung in der hausärztlichen Praxis
Guido Schmiemann, Michael Dörks, Eric Martin, et al.
Zeitschrift für Allgemeinmedizin (2024) Vol. 100, Iss. 3, pp. 136-141
Closed Access | Times Cited: 2
Evaluating the pharmacokinetics of beclometasone dipropionate/formoterol fumarate/glycopyrronium bromide delivered via pressurised metered-dose inhaler using a low global warming potential propellant
François Rony, Mauro Cortellini, Alessandro Guasconi, et al.
Pulmonary Pharmacology & Therapeutics (2024) Vol. 85, pp. 102299-102299
Open Access | Times Cited: 2
Carbon Footprints and Life Cycle Assessments of Inhalers: A Review of Published Evidence
Brett Fulford, Karen Mezzi, Simon Aumônier, et al.
Sustainability (2022) Vol. 14, Iss. 12, pp. 7106-7106
Open Access | Times Cited: 13
Effective respiratory management of asthma and COPD and the environmental impacts of inhalers
Omar S. Usmani, Mark L Levy
npj Primary Care Respiratory Medicine (2023) Vol. 33, Iss. 1
Open Access | Times Cited: 7
Impact of Inhalers Used in the Treatment of Respiratory Diseases on Global Warming
Andrzej Emeryk, Tomasz R. Sosnowski, Maciej Kupczyk, et al.
Advances in respiratory medicine (2021) Vol. 89, Iss. 4, pp. 427-438
Open Access | Times Cited: 17
Smart dry powder inhalers and intelligent adherence management
Sabine Häußermann, Laura J. Arendsen, J.N. Pritchard
Advanced Drug Delivery Reviews (2022) Vol. 191, pp. 114580-114580
Closed Access | Times Cited: 10
Dry powder inhalation, part 2: the present and future
Anne H. de Boer, Paul Hagedoorn, Floris Grasmeijer
Expert Opinion on Drug Delivery (2022) Vol. 19, Iss. 9, pp. 1045-1059
Open Access | Times Cited: 9
Excipients for Novel Inhaled Dosage Forms: An Overview
Carol Yousry, Mimansa Goyal, Vivek Gupta
AAPS PharmSciTech (2024) Vol. 25, Iss. 2
Closed Access | Times Cited: 1
Sustainable medicines use in clinical practice: A clinical pharmacological view on eco‐pharmaco‐stewardship
Elizabeth Adeyeye, Benjamin Jaa Ming New, Fangyue Chen, et al.
British Journal of Clinical Pharmacology (2021) Vol. 88, Iss. 7, pp. 3023-3029
Open Access | Times Cited: 10
Reduktion klimaschädlicher Treibhausgase durch Auswahl der Inhalatoren in der Therapie von Patienten mit Asthma und COPD
J Bickhardt, Cornelia Czupalla, Uta Bader
Pneumologie (2022) Vol. 76, Iss. 05, pp. 321-329
Open Access | Times Cited: 7
Formulation, Device, and Clinical Factors Influencing the Targeted Delivery of COVID-19 Vaccines to the Lungs
Sayeed Mossadeq, Rajen D. Shah, Viraj Shah, et al.
AAPS PharmSciTech (2022) Vol. 24, Iss. 1
Open Access | Times Cited: 7
How to engineer aerosol particle properties and biopharmaceutical performance of propellant inhalers
Precious Akhuemokhan, Natalie Armstrong Green, Allen E. Haddrell, et al.
International Journal of Pharmaceutics (2023) Vol. 634, pp. 122676-122676
Open Access | Times Cited: 3
Comparison between the intermolecular interactions in the liquid and solid forms of propellant 1,1,1,2 – Tetrafluoroethane
Vivian Walter Barron, Chin W. Yong, Alex Slowey, et al.
Journal of Molecular Liquids (2023) Vol. 383, pp. 121993-121993
Closed Access | Times Cited: 3
Towards net zero: asthma care
Laura‐Jane Smith, Ruhi Bhugra, Reem Y Kelani, et al.
BMJ (2023), pp. e072328-e072328
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top